Liposomal glycosphingolipids activate natural killer T cell-mediated immune responses through the endosomal pathway

Journal of Controlled Release

Volumn 133, Issue 1, 2009, Pages 18-23

  Inoue, Joe ^a   Ideue, Ryuichi ^a   Takahashi, Daisuke ^a   Kubota, Masahiro ^b   Kumazawa, Yoshio ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Kibun Food Chemifa Co Ltd   (Japan)

Author keywords

Endosome; Glycosphingolipid; IFN ; Liposome; Natural killer T cell

Indexed keywords

DENDRIMERS; IMMUNOLOGY; PHOSPHOLIPIDS;

DENDRITIC CELLS; ENDOSOME; GLYCOSPHINGOLIPID; GLYCOSPHINGOLIPIDS; HOST DEFENSES; IMMUNE RESPONSES; IN VITRO; IN-VIVO; LATE ENDOSOMES; NATURAL KILLER T CELL; NATURAL KILLER T CELLS; NKT CELLS; PHOSPHOETHANOLAMINE; SPHINGOMONAS; SPLENOCYTES;

LIPOSOMES;

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; CERAMIDE DERIVATIVE; CHOLESTEROL; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; GAMMA INTERFERON; GLYCOSPHINGOLIPID; IMMUNOLOGICAL ADJUVANT; LIPOSOME; PHOSPHATIDYLCHOLINE;

ANIMAL CELL; ARTICLE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DRUG EFFECT; ENDOSOME; FEMALE; MALE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; SPHINGOMONAS;

ANIMALS; ANTIGENS, CD1D; ANTIGENS, LY; CHLOROQUINE; DENDRITIC CELLS; ENDOSOMES; FATTY ACIDS, MONOUNSATURATED; FEMALE; FLOW CYTOMETRY; GLYCOSPHINGOLIPIDS; INTERFERON-GAMMA; LIPOSOMES; LIVER; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, CONFOCAL; NATURAL KILLER T-CELLS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY B; PHOSPHATIDYLETHANOLAMINES; QUATERNARY AMMONIUM COMPOUNDS; SPHINGOMONAS; SPLEEN; TOLL-LIKE RECEPTOR 4;

EID: 57049146298     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2008.09.078     Document Type: Article

References (24)

1. Park S.H., and Bendelac A. CD1-restricted T-cell responses and microbial infection. Nature. 406 6797 (2000) 788-792
2. Brigl M., and Brenner M.B. CD1: antigen presentation and T cell function. Annu. Rev. Immunol. 22 (2004) 817-890
3. Calabi F., Jarvis J.M., Martin L., and Milstein C. Two classes of CD1 genes. Eur. J. Immunol. 19 2 (1989) 285-292
4. Wu D., Zajonc D.M., Fujio M., Sullivan B.A., Kinjo Y., Kronenberg M., Wilson I.A., and Wong C.H. Design of natural killer T cell activators: structure and function of a microbial glycosphingolipid bound to mouse CD1d. Proc. Natl. Acad. Sci. U. S. A. 103 11 (2006) 3972-3977
5. Kronenberg M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 23 (2005) 877-900
6. Kinjo Y., Wu D., Kim G., Xing G.W., Poles M.A., Ho D.D., Tsuji M., Kawahara K., Wong C.H., and Kronenberg M. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434 7032 (2005) 520-525
7. Mattner J., Debord K.L., Ismail N., Goff R.D., Cantu 3rd C., Zhou D., Saint-Mezard P., Wang V., Gao Y., Yin N., Hoebe K., Schneewind O., Walker D., Beutler B., Teyton L., Savage P.B., and Bendelac A. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434 7032 (2005) 525-529
8. Sriram V., Du W., Gervay-Hague J., and Brutkiewicz R.R. Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1d-specific ligands for NKT cells. Eur. J. Immunol. 35 6 (2005) 1692-1701
9. Yabuuchi E., Kosako Y., Fujiwara N., Naka T., Matsunaga I., Ogura H., and Kobayashi K. Emendation of the genus Sphingomonas Yabuuchi et al. 1990 and junior objective synonymy of the species of three genera, Sphingobium, Novosphingobium and Sphingopyxis, in conjunction with Blastomonas ursincola. Int. J. Syst. Evol. Microbiol. 52 5 (2002) 1485-1496
10. Wittich R.M., Wilkes H., Sinnwell V., Francke W., and Fortnagel P. Metabolism of dibenzo-p-dioxin by Sphingomonas sp. strain RW1. Appl. Environ. Microbiol. 58 3 (1992) 1005-1010
11. Alving C.R. Liposomes as carriers of antigens and adjuvants. J. Immunol. Methods 140 1 (1991) 1-13
12. Singh M., and O'Hagan D.T. Recent advances in vaccine adjuvants. Pharm. Res. 19 6 (2002) 715-728
13. Christensen D., Korsholm K.S., Rosenkrands I., Lindenstrøm T., Andersen P., and Agger E.M. Cationic liposomes as vaccine adjuvants. Expert Rev. Vaccines 6 5 (2007) 785-796
14. Yotsumoto S., Kakiuchi T., and Aramaki Y. Enhancement of IFN-gamma production for Th1-cell therapy using negatively charged liposomes containing phosphatidylserine. Vaccine 25 29 (2007) 5256-5262
15. Taneichi M., Ishida H., Kajino K., Ogasawara K., Tanaka Y., Kasai M., Mori M., Nishida M., Yamamura H., Mizuguchi J., and Uchida T. Antigen chemically coupled to the surface of liposomes are cross-presented to CD8+ T cells and induce potent antitumor immunity. J. Immunol. 177 4 (2006) 2324-2330
16. Godfrey D.I., McConville M.J., and Pellicci D.G. Chewing the fat on natural killer T cell development. J. Exp. Med. 203 10 (2006) 2229-2232
17. Gadola S.D., Silk J.D., Jeans A., Illarionov P.A., Salio M., Besra G.S., Dwek R., Butters T.D., Platt F.M., and Cerundolo V. Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases. J. Exp. Med. 203 10 (2006) 2293-2303
18. Zhou D., Mattner J., Cantu 3rd C., Schrantz N., Yin N., Gao Y., Sagiv Y., Hudspeth K., Wu Y.P., Yamashita T., Teneberg S., Wang D., Proia R.L., Levery S.B., Savage P.B., Teyton L., and Bendelac A. Lysosomal glycosphingolipid recognition by NKT cells. Science 306 5702 (2004) 1786-1789
19. Chen X., Wang X., Keaton J.M., Reddington F., Illarionov P.A., Besra G.S., and Gumperz J.E. Distinct endosomal trafficking requirements for presentation of autoantigens and exogenous lipids by human CD1d molecules. J. Immunol. 178 10 (2007) 6181-6190
20. Roberts T.J., Sriram V., Spence P.M., Gui M., Hayakawa K., Bacik I., Bennink J.R., Yewdell J.W., and Brutkiewicz R.R. Recycling CD1d1 molecules present endogenous antigens processed in an endocytic compartment to NKT cells. J. Immunol. 168 11 (2002) 5409-5414
21. Bendelac A., Savage P.B., and Teyton L. The biology of NKT cells. Annu. Rev. Immunol. 25 (2007) 297-336
22. Inoue J., and Aramaki Y. Cyclooxygenase-2 inhibition promotes enhancement of antitumor responses by transcutaneous vaccination with cytosine-phosphate-guanosine-oligodeoxynucleotides and model tumor antigen. J. Invest. Dermatol. 127 3 (2007) 614-621
23. Inoue J., Yotsumoto S., Sakamoto T., Tsuchiya S., and Aramaki Y. Changes in immune responses to antigen applied to tape-stripped skin with CpG-oligodeoxynucleotide in mice. J. Control. Release 108 2-3 (2005) 294-305
24. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., Muramatsu S., and Steinman R.M. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176 6 (1992) 1693-1702